Published in Biochem J on August 15, 1993
Identification of a major cyclic AMP-dependent protein kinase A phosphorylation site within the cytoplasmic tail of the low-density lipoprotein receptor-related protein: implication for receptor-mediated endocytosis. Mol Cell Biol (2001) 1.02
Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein. Biochem J (1998) 0.94
Signal protein-derived peptides as functional probes and regulators of intracellular signaling. J Amino Acids (2011) 0.77
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
G proteins: transducers of receptor-generated signals. Annu Rev Biochem (1987) 27.41
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature (1985) 13.79
The GTPase superfamily: a conserved switch for diverse cell functions. Nature (1990) 11.71
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature (1991) 6.50
Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science (1982) 5.01
The guanine nucleotide activating site of the regulatory component of adenylate cyclase. Identification by ligand binding. J Biol Chem (1982) 3.09
Translocation of the glucose transporter (GLUT4) to the cell surface in permeabilized 3T3-L1 adipocytes: effects of ATP insulin, and GTP gamma S and localization of GLUT4 to clathrin lattices. J Cell Biol (1992) 2.71
A single amino acid substitution in rhodopsin (lysine 248----leucine) prevents activation of transducin. J Biol Chem (1988) 2.37
Insulin stimulation of gene expression mediated by p21ras activation. EMBO J (1991) 2.23
Purification of insulin receptor with full binding activity. J Biol Chem (1983) 1.82
Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. J Biol Chem (1988) 1.76
Insulin and nonhydrolyzable GTP analogs induce translocation of GLUT 4 to the plasma membrane in alpha-toxin-permeabilized rat adipose cells. J Biol Chem (1991) 1.48
A simple structure encodes G protein-activating function of the IGF-II/mannose 6-phosphate receptor. Cell (1990) 1.38
Hexose transport stimulation and membrane redistribution of glucose transporter isoforms in response to cholera toxin, dibutyryl cyclic AMP, and insulin in 3T3-L1 adipocytes. J Biol Chem (1990) 1.24
Insulin inhibits pertussis toxin-catalyzed ADP-ribosylation of G-proteins. Evidence for a novel interaction between insulin receptors and G-proteins. J Biol Chem (1988) 1.18
Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure. J Biol Chem (1992) 1.18
Synthetic peptide analogs of apolipoproteins. Methods Enzymol (1986) 1.13
The alpha-type 85-kDa subunit of phosphatidylinositol 3-kinase is phosphorylated at tyrosines 368, 580, and 607 by the insulin receptor. J Biol Chem (1993) 1.06
Effect of phenylarsine oxide on insulin-dependent protein phosphorylation and glucose transport in 3T3-L1 adipocytes. J Biol Chem (1987) 1.04
Pertussis toxin treatment attenuates some effects of insulin in BC3H-1 murine myocytes. J Biol Chem (1988) 1.02
Interaction between the p21ras GTPase activating protein and the insulin receptor. J Biol Chem (1992) 0.99
Substitution of isoleucine for methionine at position 1153 in the beta-subunit of the human insulin receptor. A mutation that impairs receptor tyrosine kinase activity, receptor endocytosis, and insulin action. J Biol Chem (1992) 0.97
Mutation in a conserved motif next to the insulin receptor key autophosphorylation sites de-regulates kinase activity and impairs insulin action. J Biol Chem (1993) 0.96
A novel guanine nucleotide-binding protein coupled to the alpha 1-adrenergic receptor. I. Identification by photolabeling or membrane and ternary complex preparation. J Biol Chem (1990) 0.94
Functional analysis of the cytoplasmic domains of the human thyrotropin receptor by site-directed mutagenesis. J Biol Chem (1990) 0.89
Some thoughts on the mechanism of action of insulin. Diabetes (1991) 0.89
G-protein-mediated regulation of the insulin-responsive glucose transporter in isolated cardiac myocytes. Biochem J (1990) 0.88
Insulin activates GTP binding to a 40 kDa protein in fat cells. Biochem J (1991) 0.86
Role of guanine nucleotide regulatory proteins in insulin stimulation of glucose transport in rat adipocytes. Influence of bacterial toxins. Biochem J (1989) 0.85
NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene. Diabetes (1992) 0.84
Insulin-stimulated phosphorylation of calmodulin. Biochem J (1992) 0.83
Insulin receptor function is inhibited by guanosine 5'-[gamma-thio]triphosphate (GTP[S]). Biochem J (1990) 0.82
Effect of GTP gamma S on insulin binding and tyrosine phosphorylation in liver membranes and L6 muscle cells. Am J Physiol (1990) 0.81
Cascade of autophosphorylation in the beta-subunit of the insulin receptor. J Cell Biochem (1989) 0.80
Activation of protein kinases by insulin and non-hydrolyzable GTP analogs in permeabilized 3T3-L1 adipocytes. J Biol Chem (1993) 0.78
Identification, partial purification, and characterization of two guanosine triphosphate-binding proteins associated with insulin receptors. Endocrinology (1992) 0.77
Insulin activates guanosine 5'-[gamma-thio] triphosphate (GTP gamma S) binding to a novel GTP-binding protein, GIR, from human placenta. Biochem Biophys Res Commun (1990) 0.77
A 68-kD GTP-binding protein associated with the T cell receptor complex. J Exp Med (1992) 0.76
Antiinflammatory properties of HDL. Circ Res (2004) 5.41
Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides. Proc Natl Acad Sci U S A (1989) 3.94
The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J Lipid Res (1992) 3.74
Amphipathic helix motif: classes and properties. Proteins (1990) 3.52
Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation (2002) 2.91
Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation (2004) 2.62
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA (1999) 2.56
The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci U S A (2004) 2.39
Apolipoprotein A-I mimetic peptides. Arterioscler Thromb Vasc Biol (2005) 2.33
Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J Lipid Res (2008) 2.27
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res (2000) 2.22
Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice. Atherosclerosis (2012) 2.19
Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. J Lipid Res (2001) 2.11
A laboratory medicine residency training program that includes clinical consultation and research. Arch Pathol Lab Med (1990) 2.07
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res (2000) 2.05
D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol (2005) 1.99
Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits. J Lipid Res (2007) 1.96
Concern Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases. Proc Natl Acad Sci U S A (2006) 1.92
Blood Lead Determinations as a Health Department Laboratory Service. Am J Public Health Nations Health (1942) 1.91
Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine. J Biol Chem (1985) 1.89
The amphipathic alpha helix: a multifunctional structural motif in plasma apolipoproteins. Adv Protein Chem (1994) 1.89
A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples. J Lipid Res (2000) 1.83
Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim Biophys Acta (2001) 1.80
Preliminary characterization of calcium binding in islet-cell plasma membranes. Diabetologia (1980) 1.75
The role of dysfunctional HDL in atherosclerosis. J Lipid Res (2008) 1.73
Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer. Proc Natl Acad Sci U S A (2010) 1.71
The metabolic fate of 13N-labeled ammonia in rat brain. J Biol Chem (1979) 1.58
Differential effect of shear stress on extracellular signal-regulated kinase and N-terminal Jun kinase in endothelial cells. Gi2- and Gbeta/gamma-dependent signaling pathways. J Biol Chem (1997) 1.57
Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly. Arterioscler Thromb Vasc Biol (1996) 1.55
Computer programs to identify and classify amphipathic alpha helical domains. J Lipid Res (1992) 1.54
Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. J Biol Chem (1992) 1.53
A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis. J Lipid Res (2001) 1.53
Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. J Biol Chem (1993) 1.50
Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice. Atherosclerosis (2012) 1.50
Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides. Biopolymers (1995) 1.48
Structure and function of HDL mimetics. Arterioscler Thromb Vasc Biol (2009) 1.40
A high affinity calcium-stimulated magnesium-dependent adenosine triphosphatase in rat adipocyte plasma membranes. J Biol Chem (1980) 1.40
Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest (2009) 1.40
Interactions of synthetic peptide analogs of the class A amphipathic helix with lipids. Evidence for the snorkel hypothesis. J Biol Chem (1994) 1.39
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids. J Lipid Res (2009) 1.37
Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation (2002) 1.37
Double belt structure of discoidal high density lipoproteins: molecular basis for size heterogeneity. J Mol Biol (2004) 1.36
Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide. Circ Res (2005) 1.35
A sensitive and precise isotopic assay of ATPase activity. Anal Biochem (1978) 1.33
Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention. Nat Clin Pract Cardiovasc Med (2006) 1.33
Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4). Hum Mol Genet (2000) 1.30
Janus kinase 2 modulates the lipid-removing but not protein-stabilizing interactions of amphipathic helices with ABCA1. J Lipid Res (2005) 1.30
Bioactivity of peptide analogs of the neutrophil chemoattractant, N-acetyl-proline-glycine-proline. Invest Ophthalmol Vis Sci (1999) 1.28
Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization. J Lipid Res (2002) 1.27
Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J Clin Invest (1994) 1.26
Truncation of the amino terminus of human apolipoprotein A-I substantially alters only the lipid-free conformation. Biochemistry (1997) 1.25
Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry (1995) 1.25
The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest (1979) 1.24
D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet. J Lipid Res (2007) 1.23
The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions. Biochemistry (1998) 1.22
Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally. J Lipid Res (2011) 1.22
Molecular basis for prokaryotic specificity of magainin-induced lysis. Biochemistry (1995) 1.21
D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation (2004) 1.20
Turnover of synthetic class A amphipathic peptide analogues of exchangeable apolipoproteins in rats. Correlation with physical properties. Arterioscler Thromb (1992) 1.19
Structural models of human apolipoprotein A-I. Biochim Biophys Acta (1995) 1.19
HDL as a biomarker, potential therapeutic target, and therapy. Diabetes (2009) 1.19
Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid. J Biol Chem (1999) 1.19
Effect of end group blockage on the properties of a class A amphipathic helical peptide. Proteins (1993) 1.19
The role of high-density lipoprotein in inflammation. Trends Cardiovasc Med (2005) 1.17
Monoclonal antibody to calmodulin: development, characterization, and comparison with polyclonal anti-calmodulin antibodies. Anal Biochem (1991) 1.17
Sequence conservation of apolipoprotein A-I affords novel insights into HDL structure-function. J Lipid Res (2010) 1.17
ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers. J Biol Chem (2006) 1.16
Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity. J Biol Chem (2004) 1.15
Influence of ApoA-I structure on the ABCA1-mediated efflux of cellular lipids. J Biol Chem (2004) 1.15
Apolipoprotein E mimetic Peptide dramatically lowers plasma cholesterol and restores endothelial function in watanabe heritable hyperlipidemic rabbits. Circulation (2005) 1.14
Apolipoprotein A-I mimetic peptides. Curr Atheroscler Rep (2009) 1.13
Energy-dependent calcium transport in endoplasmic reticulum of adipocytes. J Biol Chem (1976) 1.13
Structure and function of apolipoprotein A-I and high-density lipoprotein. Curr Opin Lipidol (2000) 1.13
D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice. J Lipid Res (2011) 1.13
Synthetic peptide analogs of apolipoproteins. Methods Enzymol (1986) 1.13
Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation. J Clin Invest (1990) 1.13
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol (2005) 1.12
Insulin effect on protein phosphorylation of plasma membranes and mitochondria in a subcellular system from rat adipocytes. I. Identification of insulin-sensitive phosphoproteins. J Biol Chem (1979) 1.12
Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages. Am J Physiol Cell Physiol (2010) 1.12
L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways. Integr Biol (Camb) (2011) 1.11
D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet. J Lipid Res (2006) 1.10
Osmotically induced membrane tension modulates membrane permeabilization by class L amphipathic helical peptides: nucleation model of defect formation. Biophys J (2001) 1.10
The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts. Biochemistry (2000) 1.10
Insulin stimulates the phosphorylation of calmodulin in intact adipocytes. J Biol Chem (1987) 1.09
A novel approach to oral apoA-I mimetic therapy. J Lipid Res (2013) 1.09
apoB-100 has a pentapartite structure composed of three amphipathic alpha-helical domains alternating with two amphipathic beta-strand domains. Detection by the computer program LOCATE. Arterioscler Thromb (1994) 1.08
Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats. Am J Physiol Heart Circ Physiol (2009) 1.07
Polymerase chain reaction to detect cytomegalovirus DNA in the cerebrospinal fluid of neonates with congenital infection. J Infect Dis (1994) 1.06
Reference laboratory administrative reengineering. Am J Clin Pathol (1997) 1.06
Multiple indications for anti-inflammatory apolipoprotein mimetic peptides. Curr Opin Investig Drugs (2008) 1.06
Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes. Biochemistry (1998) 1.06
The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein. J Biol Chem (1994) 1.05
Tandem repeat of C/EBP binding sites mediates PPARgamma2 gene transcription in glucocorticoid-induced adipocyte differentiation. J Cell Biochem (2000) 1.05
Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin. Am J Pathol (1999) 1.05
Circular dichroism of protein and glycoprotein fish antifreezes. Biopolymers (1977) 1.04
A high-performance liquid chromatography method for hemoglobin A1c. Diabetes (1978) 1.04
Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid. J Lipid Res (2013) 1.03
Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease. Neurobiol Dis (2009) 1.03
Association of a model class A (apolipoprotein) amphipathic alpha helical peptide with lipid: high resolution NMR studies of peptide.lipid discoidal complexes. J Biol Chem (2006) 1.03
Saturated fatty acid-induced insulin resistance in rat adipocytes. Diabetes (1994) 1.03